108 related articles for article (PubMed ID: 16455253)
21. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
22. Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis.
Yee NK; Farina V; Houpis IN; Haddad N; Frutos RP; Gallou F; Wang XJ; Wei X; Simpson RD; Feng X; Fuchs V; Xu Y; Tan J; Zhang L; Xu J; Smith-Keenan LL; Vitous J; Ridges MD; Spinelli EM; Johnson M; Donsbach K; Nicola T; Brenner M; Winter E; Kreye P; Samstag W
J Org Chem; 2006 Sep; 71(19):7133-45. PubMed ID: 16958506
[TBL] [Abstract][Full Text] [Related]
23. Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.
Shaw AN; Tedesco R; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Duffy KJ; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Liu N; Sarisky RT; Wiggall KJ; Zimmerman MN
Bioorg Med Chem Lett; 2009 Aug; 19(15):4350-3. PubMed ID: 19515564
[TBL] [Abstract][Full Text] [Related]
24. [New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)].
Kato N; Muroyama R
Nihon Rinsho; 2011 May; 69 Suppl 4():275-81. PubMed ID: 22096931
[No Abstract] [Full Text] [Related]
25. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
27. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
28. Practical synthesis of a potent hepatitis C virus RNA replication inhibitor.
Bio MM; Xu F; Waters M; Williams JM; Savary KA; Cowden CJ; Yang C; Buck E; Song ZJ; Tschaen DM; Volante RP; Reamer RA; Grabowski EJ
J Org Chem; 2004 Sep; 69(19):6257-66. PubMed ID: 15357584
[TBL] [Abstract][Full Text] [Related]
29. Treating hepatitis C in lower-income countries.
Jayasekera CR; Barry M; Roberts LR; Nguyen MH
N Engl J Med; 2014 May; 370(20):1869-71. PubMed ID: 24720680
[No Abstract] [Full Text] [Related]
30. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
Patil VM; Gupta SP; Samanta S; Masand N
Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
[TBL] [Abstract][Full Text] [Related]
31. Isolation and identification of ester impurities in RG7128, an HCV polymerase inhibitor.
Chow J; Liu Y; Comstock K; Brandl M; Lin F; Li F; Sarma K; Alfredson T
J Pharm Biomed Anal; 2010 Nov; 53(3):710-6. PubMed ID: 20439144
[TBL] [Abstract][Full Text] [Related]
32. [Development status of DAA against hepatitis C].
Kato N; Nakagawa R; Goto K; Muroyama R; Matsubara Y
Nihon Rinsho; 2015 Dec; 73 Suppl 9():262-8. PubMed ID: 26845942
[No Abstract] [Full Text] [Related]
33. A selective 3-acylation of tetramic acids and the first synthesis of ravenic acid.
Schlenk A; Diestel R; Sasse F; Schobert R
Chemistry; 2010 Feb; 16(8):2599-604. PubMed ID: 20066698
[TBL] [Abstract][Full Text] [Related]
34. Highly functionalized and potent antiviral cyclopentane derivatives formed by a tandem process consisting of organometallic, transition-metal-catalyzed, and radical reaction steps.
Jagtap PR; Ford L; Deister E; Pohl R; Císařová I; Hodek J; Weber J; Mackman R; Bahador G; Jahn U
Chemistry; 2014 Aug; 20(33):10298-304. PubMed ID: 25043655
[TBL] [Abstract][Full Text] [Related]
35. Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques.
Gil C; Dorronsoro I; Castro A; Martinez A
Bioorg Med Chem Lett; 2005 Apr; 15(7):1919-21. PubMed ID: 15780633
[TBL] [Abstract][Full Text] [Related]
36. Solid-phase synthesis of anagrelide sulfonyl analogues.
McMaster C; Fülöpová V; Popa I; Grepl M; Soural M
ACS Comb Sci; 2014 May; 16(5):221-4. PubMed ID: 24725158
[TBL] [Abstract][Full Text] [Related]
37. Total synthesis and absolute configuration of macrocidin A, a cyclophane tetramic acid natural product.
Yoshinari T; Ohmori K; Schrems MG; Pfaltz A; Suzuki K
Angew Chem Int Ed Engl; 2010; 49(5):881-5. PubMed ID: 20039248
[No Abstract] [Full Text] [Related]
38. Solid-phase synthesis of a 4-substituted gamma-lactam library.
Vergnon AL; Pottorf RS; Winters MP; Player MR
J Comb Chem; 2004; 6(6):903-10. PubMed ID: 15530117
[TBL] [Abstract][Full Text] [Related]
39. Chlorophenylmethyl benzothiadiazine dioxides derivatives: potent human cytomegalovirus inhibitors.
Martinez A; Gil C; Perez C; Castro A; Prieto C; Otero J
Bioorg Med Chem Lett; 1999 Nov; 9(21):3133-6. PubMed ID: 10560739
[TBL] [Abstract][Full Text] [Related]
40. Efficient synthesis of 2,4-disubstituted 1,2,4-benzothiadiazin-3-one 1,1-dioxides on solid support.
Makino S; Nakanishi E; Tsuji T
J Comb Chem; 2003; 5(1):73-8. PubMed ID: 12523837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
